Thomas Kawano

Summary

Publications

  1. pmc Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease
    Adam Keene
    Crit Care 12:405. 2008

Detail Information

Publications1

  1. pmc Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease
    Adam Keene
    Crit Care 12:405. 2008